Human papillomavirus inhibitors
    3.
    发明申请
    Human papillomavirus inhibitors 审中-公开
    人乳头状瘤病毒抑制剂

    公开(公告)号:US20050123902A1

    公开(公告)日:2005-06-09

    申请号:US10851407

    申请日:2004-05-21

    摘要: The present invention provides systems for identifying anti-viral agents. In particular, the invention encompasses reagents and strategies for identifying agents that inhibit or disrupt key protein-protein interactions that are important in the life cycle of papillomaviruses. The invention allows identification, production, and/or use of agents that reduce or inhibit the replication of HPV by inhibiting (e.g., precluding, reversing, or disrupting) the formation of the E1-E2 protein-protein complex. The invention also provides specific inhibitory agents, pharmaceutical compositions, and methods of using these inhibitors and pharmaceutical compositions for inhibiting viral replication in vitro. Methods are also described for the treatment and prevention of HPV infections and HPV-related diseases in patients.

    摘要翻译: 本发明提供用于鉴定抗病毒剂的系统。 特别地,本发明包括用于鉴定抑制或破坏在乳头状瘤病毒生命周期中重要的关键蛋白质 - 蛋白质相互作用的试剂的策略。 本发明允许通过抑制(例如排除,逆转或破坏)E1-E2蛋白 - 蛋白复合物的形成来鉴定,产生和/或使用降低或抑制HPV复制的药剂。 本发明还提供特异性抑制剂,药物组合物和使用这些抑制剂和药物组合物用于体外抑制病毒复制的方法。 还描述了用于治疗和预防患者的HPV感染和HPV相关疾病的方法。